Risk stratification for sudden cardiac death in hypertrophic cardiomyopathy: Dutch cardiologists and the care of mutation carriers.

Cardiomyopathies: a revolution in molecular medicine and cardiac imaging. Neth Heart J (2009) 0.82

Evaluation of hypertrophic cardiomyopathy: new horizons for CMR? Neth Heart J (2010) 0.81

Speckle tracking: distinction of physiologic from pathologic LVH? Int J Cardiovasc Imaging (2010) 0.78

Left ventricular mass assessment by CMR; how to define the optimal index. Int J Cardiovasc Imaging (2010) 0.75

Contemporary definitions and classification of the cardiomyopathies: an American Heart Association Scientific Statement from the Council on Clinical Cardiology, Heart Failure and Transplantation Committee; Quality of Care and Outcomes Research and Functional Genomics and Translational Biology Interdisciplinary Working Groups; and Council on Epidemiology and Prevention. Circulation (2006) 9.44

ACC/AHA/HRS 2008 Guidelines for Device-Based Therapy of Cardiac Rhythm Abnormalities: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the ACC/AHA/NASPE 2002 Guideline Update for Implantation of Cardiac Pacemakers and Antiarrhythmia Devices): developed in collaboration with the American Association for Thoracic Surgery and Society of Thoracic Surgeons. Circulation (2008) 8.94

Prevalence of hypertrophic cardiomyopathy in a general population of young adults. Echocardiographic analysis of 4111 subjects in the CARDIA Study. Coronary Artery Risk Development in (Young) Adults. Circulation (1995) 6.55

Classification of the cardiomyopathies: a position statement from the European Society Of Cardiology Working Group on Myocardial and Pericardial Diseases. Eur Heart J (2007) 6.34

ACC/AHA/ESC 2006 Guidelines for Management of Patients With Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death: a report of the American College of Cardiology/American Heart Association Task Force and the European Society of Cardiology Committee for Practice Guidelines (writing committee to develop Guidelines for Management of Patients With Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death): developed in collaboration with the European Heart Rhythm Association and the Heart Rhythm Society. Circulation (2006) 5.95

American College of Cardiology/European Society of Cardiology clinical expert consensus document on hypertrophic cardiomyopathy. A report of the American College of Cardiology Foundation Task Force on Clinical Expert Consensus Documents and the European Society of Cardiology Committee for Practice Guidelines. J Am Coll Cardiol (2003) 5.86

Mutations in the gene for cardiac myosin-binding protein C and late-onset familial hypertrophic cardiomyopathy. N Engl J Med (1998) 4.29

Sudden death in hypertrophic cardiomyopathy: identification of high risk patients. J Am Coll Cardiol (2000) 2.89

Hypertrophic cardiomyopathy. Lancet (2004) 2.41

Genetic basis of hypertrophic cardiomyopathy: from bench to the clinics. J Cardiovasc Electrophysiol (2007) 2.18

Epidemiology of hypertrophic cardiomyopathy-related death: revisited in a large non-referral-based patient population. Circulation (2000) 2.12

Awareness and perception of heart failure among European cardiologists, internists, geriatricians, and primary care physicians. Eur Heart J (2008) 1.80

Experience from clinical genetics in hypertrophic cardiomyopathy: proposal for new diagnostic criteria in adult members of affected families. Heart (1997) 1.72

Genetic knowledge and counselling skills of Dutch cardiologists: sufficient for the genomics era? Eur Heart J (2003) 1.52

Historical trends in reported survival rates in patients with hypertrophic cardiomyopathy. Heart (2005) 1.24

Cardiologist's knowledge and attitudes about obstructive sleep apnea: a survey study. Sleep Breath (2008) 0.86

Risk stratification of sudden cardiac death in hypertrophic cardiomyopathy. Nat Clin Pract Cardiovasc Med (2007) 0.85

Empirical evidence of design-related bias in studies of diagnostic tests. JAMA (1999) 12.96

A single Na(+) channel mutation causing both long-QT and Brugada syndromes. Circ Res (2000) 3.68

Test-retest reliability of health state valuations collected with the EuroQol questionnaire. Soc Sci Med (1994) 3.31

Estimating clinical morbidity due to ischemic heart disease and congestive heart failure: the future rise of heart failure. Am J Public Health (1994) 3.10

A comparison of continuous thalamic stimulation and thalamotomy for suppression of severe tremor. N Engl J Med (2000) 2.92

Comparative assessment of pediatric intensive care: a national multicenter study. Pediatric Intensive Care Assessment of Outcome (PICASSO) Study Group. Crit Care Med (1995) 2.78

Long-term prognosis of patients diagnosed with Brugada syndrome: Results from the FINGER Brugada Syndrome Registry. Circulation (2010) 2.53

An empirical comparison of four generic health status measures. The Nottingham Health Profile, the Medical Outcomes Study 36-item Short-Form Health Survey, the COOP/WONCA charts, and the EuroQol instrument. Med Care (1997) 2.30

Identification of a possible pathogenic link between congenital long QT syndrome and epilepsy. Neurology (2008) 2.21

Preoperative prediction of severe postoperative pain. Pain (2003) 2.11

Nuchal translucency screening and anxiety levels in pregnancy and puerperium. Ultrasound Obstet Gynecol (2006) 2.03

Economic evaluation of the administration of follitropin-beta with a pen device. Reprod Biomed Online (2005) 1.99

[Class substitution as an instrument of efficiency in the supply of medicines: possibilities and limitations]. Ned Tijdschr Geneeskd (2002) 1.97

[Possibilities for anonymous follow-up studies of patients in Dutch national medical registrations using the Municipal Population Register: a pilot study]. Ned Tijdschr Geneeskd (2003) 1.94

Novel empirical disability weights to assess the burden of non-fatal injury. Inj Prev (2008) 1.90

Is T-wave alternans testing feasible in candidates for prophylactic implantable defibrillators? Neth Heart J (2011) 1.89

Bibliometric data in clinical cardiology revisited. The case of 37 Dutch professors. Neth Heart J (2011) 1.79

Catecholaminergic polymorphic ventricular tachycardia: RYR2 mutations, bradycardia, and follow up of the patients. J Med Genet (2005) 1.78

Increased adverse perinatal outcome of hospital delivery at night. BJOG (2010) 1.77

The effect of adding a cognitive dimension to the EuroQol multiattribute health-status classification system. J Clin Epidemiol (1999) 1.77

Effect of screening for red cell antibodies, other than anti-D, to detect hemolytic disease of the fetus and newborn: a population study in the Netherlands. Transfusion (2008) 1.75

Higher maternal TSH levels in pregnancy are associated with increased risk for miscarriage, fetal or neonatal death. Eur J Endocrinol (2009) 1.68

Novel Brugada syndrome-causing mutation in ion-conducting pore of cardiac Na+ channel does not affect ion selectivity properties. Acta Physiol Scand (2005) 1.67

Reliability and validity of the child health questionnaire-child form (CHQ-CF87) in a Dutch adolescent population. Qual Life Res (2002) 1.64

Late start of antenatal care among ethnic minorities in a large cohort of pregnant women. BJOG (2007) 1.64

Quantification of the level descriptors for the standard EQ-5D three-level system and a five-level version according to two methods. Qual Life Res (2008) 1.60

Clinical relevance of diagnosing structural chromosome abnormalities in couples with repeated miscarriage. Hum Reprod (2004) 1.57

[Initial diagnostic strategy in the case of transient losses of consciousness: the importance of the medical history]. Ned Tijdschr Geneeskd (2003) 1.55

Auditory stimuli as a trigger for arrhythmic events differentiate HERG-related (LQTS2) patients from KVLQT1-related patients (LQTS1). J Am Coll Cardiol (1999) 1.54

Genetic knowledge and counselling skills of Dutch cardiologists: sufficient for the genomics era? Eur Heart J (2003) 1.52

[No spectacular rise in claims for medical damages in The Netherlands: 1993-'01 compared to 1980-'90]. Ned Tijdschr Geneeskd (2004) 1.51

Increasing maternal age at first pregnancy planning: health outcomes and associated costs. J Epidemiol Community Health (2010) 1.48

Does lung transplantation prolong life? A comparison of survival with and without transplantation. J Heart Lung Transplant (1998) 1.47

[Genetic identification of patients and families with a long-QT syndrome: large regional differences in the result of 10 years]. Ned Tijdschr Geneeskd (2007) 1.46

[The budget control function of the Drug Reimbursement System]. Ned Tijdschr Geneeskd (2002) 1.42

Cost-effectiveness of a family and DNA based screening programme on familial hypercholesterolaemia in The Netherlands. Eur Heart J (2002) 1.41

The works of Dirk Durrer (1918-1984). Neth Heart J (2012) 1.39

[Medication for ADHD and the risk of cardiovascular mortality]. Ned Tijdschr Geneeskd (2006) 1.39

The discount rate in the economic evaluation of prevention: a thought experiment. J Epidemiol Community Health (2001) 1.38

Generalizability of valuations on health states collected with the EuroQolc-questionnaire. Health Econ (1993) 1.32

The Hirsch-index: a simple, new tool for the assessment of scientific output of individual scientists: The case of Dutch professors in clinical cardiology. Neth Heart J (2009) 1.30

Associations between dietary patterns and semen quality in men undergoing IVF/ICSI treatment. Hum Reprod (2009) 1.30

Measuring quality of health care from the user's perspective in 41 countries: psychometric properties of WHO's questions on health systems responsiveness. Qual Life Res (2007) 1.26

Reliability and validity of the Satisfaction with Hospital Care Questionnaire. Int J Qual Health Care (2002) 1.24

Randomized controlled trial of total intravenous anesthesia with propofol versus inhalation anesthesia with isoflurane-nitrous oxide: postoperative nausea with vomiting and economic analysis. Anesthesiology (2001) 1.19

The comparability and reliability of five health-state valuation methods. Soc Sci Med (1997) 1.19

The use of genotype-phenotype correlations in mutation analysis for the long QT syndrome. J Med Genet (2003) 1.13

Risk factors for preeclampsia in nulliparous women in distinct ethnic groups: a prospective cohort study. Obstet Gynecol (1998) 1.11

The cardiac sodium channel displays differential distribution in the conduction system and transmural heterogeneity in the murine ventricular myocardium. Basic Res Cardiol (2009) 1.11

Is psychosocial stress in first ongoing pregnancies associated with pre-eclampsia and gestational hypertension? BJOG (2008) 1.10

[The determinants of the high Dutch perinatal mortality in a complete regional cohort, 1990-1994]. Ned Tijdschr Geneeskd (2004) 1.10

Cost-effectiveness of stereotactic large-core needle biopsy for nonpalpable breast lesions compared to open-breast biopsy. Br J Cancer (2004) 1.10

Cost-effectiveness of in vitro fertilization and embryo transfer. Fertil Steril (2000) 1.09

The relation between TISS and real paediatric ICU costs: a case study with generalizable methodology. Intensive Care Med (1998) 1.09

Ethnic differences in preterm birth and its subtypes: the effect of a cumulative risk profile. BJOG (2008) 1.08

An efficient validation method of probabilistic record linkage including readmissions and twins. Methods Inf Med (2008) 1.06

An urban perinatal health programme of strategies to improve perinatal health. Matern Child Health J (2012) 1.06

Polytopic anomalies with agenesis of the lower vertebral column. Am J Med Genet (1999) 1.06

The effect of neighbourhood income and deprivation on pregnancy outcomes in Amsterdam, The Netherlands. J Epidemiol Community Health (2009) 1.05

Desmin-related myopathy. Clin Genet (2010) 1.05

[Perinatal outcomes in the four largest cities and in deprived neighbourhoods in The Netherlands]. Ned Tijdschr Geneeskd (2008) 1.05

Decreasing perinatal mortality in The Netherlands, 2000-2006: a record linkage study. J Epidemiol Community Health (2009) 1.04

Measuring health status using the Health Utilities Index: agreement between raters and between modalities of administration. J Clin Epidemiol (2001) 1.04

Immunotherapy with autologous tumor cell-BCG vaccine in patients with colon cancer: a prospective study of medical and economic benefits. Vaccine (2005) 1.04

Long-term survival and state of health after paediatric intensive care. Arch Dis Child (1995) 1.03

Anonymous non-response analysis in the ABCD cohort study enabled by probabilistic record linkage. Paediatr Perinat Epidemiol (2009) 1.00

Effectiveness and efficiency of a Dutch pediatric intensive care unit: validity and application of the Pediatric Risk of Mortality score. Crit Care Med (1994) 1.00

Impact of cardiac complications on outcome after aneurysmal subarachnoid hemorrhage: a meta-analysis. Neurology (2009) 1.00

The PROTON study: profiles of blood product transfusion recipients in the Netherlands. Vox Sang (2010) 0.98

Family and population strategies for screening and counselling of inherited cardiac arrhythmias. Ann Med (2004) 0.98

Bridging between professionals in perinatal care: towards shared care in the Netherlands. Matern Child Health J (2013) 0.97

Screening in pregnancy for fetal or neonatal alloimmune thrombocytopenia: systematic review. BJOG (2010) 0.97

Meta-analysis shows clinically relevant and long-lasting deterioration in health-related quality of life after esophageal cancer surgery. Qual Life Res (2013) 0.97

Maternal pre-pregnancy body mass index explains infant's weight and BMI at 14 months: results from a multi-ethnic birth cohort study. Arch Dis Child (2009) 0.97

Risk factors for RhD immunisation despite antenatal and postnatal anti-D prophylaxis. BJOG (2009) 0.96

Record linkage: making the most out of errors in linking variables. AMIA Annu Symp Proc (2006) 0.96

The impact of migraine on health status. Headache (1995) 0.96

Extension of the clinical spectrum of Danon disease. Neurology (2008) 0.95

Fever-triggered ventricular arrhythmias in Brugada syndrome and type 2 long-QT syndrome. Neth Heart J (2010) 0.94

First experience with the wearable cardioverter defibrillator in the Netherlands. Neth Heart J (2012) 0.94

Technology assessment of the Dutch Lung Transplantation Program. Int J Technol Assess Health Care (1998) 0.94

Recurrent and founder mutations in the Netherlands-Phospholamban p.Arg14del mutation causes arrhythmogenic cardiomyopathy. Neth Heart J (2013) 0.94

Left cardiac sympathetic denervation in the Netherlands for the treatment of inherited arrhythmia syndromes. Neth Heart J (2014) 0.93

Alternative approaches to derive disability weights in injuries: do they make a difference? Qual Life Res (2009) 0.93

Under what conditions do patients want to be informed about their risk of a complication? A vignette study. J Med Ethics (2009) 0.93

Founder mutations in hypertrophic cardiomyopathy patients in the Netherlands. Neth Heart J (2010) 0.92

ECG determinants in adult patients with chronic right ventricular pressure overload caused by congenital heart disease: relation with plasma neurohormones and MRI parameters. Heart (2002) 0.92

The sense and nonsense of direct-to-consumer genetic testing for cardiovascular disease. Neth Heart J (2011) 0.91

Recurrent and founder mutations in the Netherlands : Plakophilin-2 p.Arg79X mutation causing arrhythmogenic right ventricular cardiomyopathy/dysplasia. Neth Heart J (2010) 0.91

Karyotyping or rapid aneuploidy detection in prenatal diagnosis? The different views of users and providers of prenatal care. BJOG (2009) 0.91

Individualized choice in prenatal diagnosis: the impact of karyotyping and standalone rapid aneuploidy detection on quality of life. Prenat Diagn (2010) 0.91

The added value that increasing levels of diagnostic information provide in prognostic models to estimate hospital mortality for adult intensive care patients. Intensive Care Med (2000) 0.91